HepaLife Technologies, Inc. -- Dr. Ayesha Mahmood Joins Research Team
02. August 2004 09:30 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, Aug. 2, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on the research, development and eventual...
HepaLife Receives Approval for Trading on Frankfurt Stock Exchange
06. Juli 2004 09:30 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, July 6, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), an early stage biotechnology company focused on developing the first of its kind artificial liver...
HepaLife Announces Formation of Distinguished Scientific Advisory Board
15. Juni 2004 10:09 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, June 15, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on the research, development and eventual...
HepaLife Announces Expansion and Extension of Cooperative Research Agreement
01. Juni 2004 06:30 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, June 1, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on the research, development and eventual...
HepaLife Expands into Developing Technology for Hepatotoxicity, the Most Common Reason Cited for the Withdrawal of an Approved Drug, Pre-Clinical Drug Failures, and for Refusal of Drug Approval by the FDA
14. Mai 2004 14:28 ET
|
HepaLife Technologies, Inc.
VANCOUVER, B.C., May 14, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on technologies and products to treat various forms of liver...
HepaLife Approved for Listing on Berlin Bremen Exchange
14. April 2004 14:37 ET
|
HepaLife Technologies, Inc.
VANCOUVER, B.C., April 14, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce that effective immediately the Company has been approved for dual listing on the Berlin...
HepaLife Announces Results of First Phase Research
07. Januar 2004 10:00 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, Jan. 7, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce the initial results of its first phase of research towards the development of...
HepaLife to Release Latest Research Results
17. Dezember 2003 09:20 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, Dec. 17, 2003 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB: HPLF) is pleased to announce that it will be releasing the results of recent scientific research on the...
HepaLife appoints Mr. Jasvir S. Kheleh as Director
20. November 2003 14:35 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, Nov. 20, 2003 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce the appointment of Mr. Jasvir S. Kheleh as a Director, a position previously...
Hepatitis Now More Prevalent Than AIDS; HepaLife Developing Artificial Liver in Response to Growing Base of Liver Disease Sufferers
07. Oktober 2003 09:30 ET
|
HepaLife Technologies, Inc.
VANCOUVER, British Columbia, Oct. 7, 2003 (PRIMEZONE) -- Accounting for an estimated 40% of all deaths due to chronic liver disease, hepatitis C is a deadly virus that enters the blood system and...